Table 2 . Improvement of scores (ANCOVA) complete case analysis.
TAU |
ICBT |
||||||
---|---|---|---|---|---|---|---|
M | SD | 95% CI | M | SD | 95% CI | Statistical significance | |
BDI-II pre-post n = 65 | − 11.63 | 9.88 | − 8.24, − 15.02 | − 12.27 | 10.94 | − 8.18, − 16.35 | F(1,62) = .02, NS |
MADRS-S week 0–3 n = 66 | − 2.12 | 5.56 | − 0.18, − 4.06 | − 0.91 | 6.12 | 1.30, − 3.11 | F(l,63) = .84, NS |
MADRS-S week 0–7 n = 58 | − 6.24 | 8.16 | − 3.14, − 9.35 | − 4.31 | 7.96 | − 1.28, − 7.34 | F(1,55) = .85, NS |
MADRS-S pre-post n = 65 | − 8.46 | 7.64 | − 5.83, − 11.08 | − 7.67 | 9.79 | − 4.01, − 11.32 | F(1,62) = .16, NS |
BAI pre-post*n = 65 | − 6.71 | 9.03 | − 3.61, − 9.82 | − 5.93 | 9.17 | − 2.51, − 9.36 | F(l,62) = .22, NS |
Notes. Negative values indicate improvement. Covariat pre-treatment scores for the same scale except for *BAI where covariat is pre-treatment scores for BDI-II.